EMA — authorised 28 March 2018
- Status: approved
EMA authorised Shingrix on 28 March 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 28 March 2018.
GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.